Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2019 Publisher: LEO Pharma Ltd, Auckland, New Zealand, Ph: 0800 497 456
Fucicort fusidic acid 20 mg/g and betamethasone 1 mg/g (as valerate) cream.
Pharmaceutical Form |
---|
Fucicort is a white cream containing fusidic acid and betamethasone valerate in a |
Each gram of cream contains active ingredients fusidic acid 20mg and betamethasone (as valerate) 1mg.
Excipients of known effect: cetostearyl alcohol 72 mg/g and chlorocresol 1 mg/g.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Betamethasone |
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |
|
Fusidic acid |
Fusidic acid belongs to a unique group of antibiotics, the fusidanes, which act to inhibit bacterial protein synthesis by blocking the lengthening of factor G. Fusidic acid is active against staphylococcus epidermidis and methicillin resistant staphylococci. |
List of Excipients |
---|
Macrogol cetostearyl ether (Cetomacrogol 1000) |
15 g.
LEO Pharma Ltd, Auckland, New Zealand, Ph: 0800 497 456
31 July 1986
Drug | Countries | |
---|---|---|
FUCICORT | Cyprus, Ecuador, Estonia, Finland, Hong Kong, Israel, Lithuania, Malta, Mexico, New Zealand, Romania, Singapore, Turkey |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.